Bat (botulism antitoxin heptavalent)
(Botulism Antitoxin Heptavalent)Emergent BIoSolutions Canada Inc.
Usage: Botulism Antitoxin Heptavalent (BAT) is indicated for treating symptomatic botulism after documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, F, or G in both adults and pediatric patients. Its effectiveness is supported by studies in animal models.